The estimated Net Worth of John Onopchenko is at least $89.8 Tausend dollars as of 12 August 2020. John Onopchenko owns over 88,978 units of Endologix stock worth over $36,454 and over the last 7 years John sold ELGX stock worth over $53,387.
John has made over 2 trades of the Endologix stock since 2019, according to the Form 4 filled with the SEC. Most recently John sold 88,978 units of ELGX stock worth $53,387 on 12 August 2020.
The largest trade John's ever made was selling 88,978 units of Endologix stock on 12 August 2020 worth over $53,387. On average, John trades about 10,840 units every 45 days since 2017. As of 12 August 2020 John still owns at least 165,698 units of Endologix stock.
You can see the complete history of John Onopchenko stock trades at the bottom of the page.
John's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott und Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: